Targeting BCL-XL in fibrolamellar hepatocellular carcinoma

Shebl, B; Ng, D; Lalazar, G; Rosemore, C; Finkelstein, TM; Migler, RD; Zheng, GR; Zhang, PY; Jiang, CS; Qureshi, A; Vaughan, R; Yarchoan, M; de Jong, YP; Rice, CM; Coffino, P; Ortiz, MV; Zhou, DH; Simon, SM

Simon, SM (通讯作者),Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.

JCI INSIGHT, 2022; 7 (17):

Abstract

Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no proven effective systemic therapy. Inhibition of the anti......

Full Text Link